On Monday, Terns Pharmaceuticals Inc (NASDAQ: TERN) opened higher 13.30% from the last session, before settling in for the closing price of $22.56. Price fluctuations for TERN have ranged from $1.87 to $23.31 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 16.38%. Company’s average yearly earnings per share was noted 2.52% at the time writing. With a float of $75.64 million, this company’s outstanding shares have now reached $87.51 million.
Terns Pharmaceuticals Inc (TERN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Terns Pharmaceuticals Inc is 16.03%, while institutional ownership is 80.52%. The most recent insider transaction that took place on Nov 04 ’25, was worth 441,360. In this transaction Director of this company sold 24,520 shares at a rate of $18.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 04 ’25, when Company’s Director proposed sale 24,520 for $14.03, making the entire transaction worth $344,016.
Terns Pharmaceuticals Inc (TERN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.24 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.3) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.39% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Check out the current performance indicators for Terns Pharmaceuticals Inc (TERN). In the past quarter, the stock posted a quick ratio of 19.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Looking closely at Terns Pharmaceuticals Inc (NASDAQ: TERN), its last 5-days average volume was 4.08 million, which is a jump from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 91.92%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 97.51%, which indicates a significant increase from 96.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.81 in the past 14 days, which was higher than the 0.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.48, while its 200-day Moving Average is $5.77. However, in the short run, Terns Pharmaceuticals Inc’s stock first resistance to watch stands at $26.91. Second resistance stands at $28.26. The third major resistance level sits at $30.40. If the price goes on to break the first support level at $23.42, it is likely to go to the next support level at $21.28. Now, if the price goes above the second support level, the third support stands at $19.93.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
There are currently 90,080K shares outstanding in the company with a market cap of 2.30 billion. Presently, the company’s annual sales total 0 K according to its annual income of -88,850 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,090 K.
